Pharmacological and interventional controversies in ACS

Learning Objectives

  • To learn about the upstream and downstream antithrombotic options for NSTE-ACS patients undergoing invasive management
  • To identify how to best manage STEMI patients with large thrombus burden
  • To analyse how pharmacological strategies and mechanical interventions should be harmonised in clinical practice

Presentations available when logged in:

  • Introduction and objectives
  • Presentation of a NSTE-ACS case
  • Skip pretreatment, load the patient with prasugrel in the lab
  • Skip pretreatment, let cangrelor do the job
  • Pretreat them all, no way I am going to change my practice!
  • STEMI - Presentation of a case treated with delayed stenting
  • My mechanical approach to thrombus removal in STEMI
  • My pharmacological approach for high thrombus burden in STEMI
  • All we need is heparin and modern P2Y12 agents
  • Take-home message